Nishi Kyoko, Kanemaru Kazuya, Hasegawa Shu, Watanabe Arata, Diksic Mirko
Department of Neurology and Neurosurgery, and Montreal Neurological Institute, McGill University, Quebec, Canada.
Neurochem Int. 2009 Mar-Apr;54(3-4):205-14. doi: 10.1016/j.neuint.2008.10.010. Epub 2008 Nov 25.
The main objective of this investigation was to evaluate the effects of buspirone, a 5-HT(1A) agonist with some partial agonist properties and also an antidepressant, on regional 5-HT synthesis in Flinders Sensitive Line (FSL) rats ("depressed"), and to compare the effects to the Flinders Resistant Line (FRL) control rats (not "depressed"). In addition results were compared to those previously reported in normal Sprague-Dawley (SPD) rats (normal control). Serotonin synthesis in both FSL and FRL rats was measured following acute and chronic treatments with buspirone. Both of these strains were derived from the SPD rats. No direct comparison was done between the FSL saline and FRL saline groups, or the FSL buspirone and FRL buspirone groups, because the objective of the studies was to evaluate effects of buspirone in these two strains. The results show that acute treatment with buspirone elevates 5-HT synthesis throughout the brain in the FRL rats. In the FSL rats, there were reductions in some brain regions (e.g., dorsal and median raphe, amygdala, anterior olfactory nucleus, substantia nigra reticulate), while in other regions, there were increases in the synthesis observed (e.g., frontal, parietal, visual and somatosensory cortices, ventral hippocampus). In 20 out of the 30 brain regions investigated in the FSL rats, there was no significant change in the synthesis following acute buspirone treatment. During the chronic treatment, buspirone produced a significant reduction of 5-HT synthesis in 15 out of 30 brain regions in the FRL rats. In the FSL rats, buspirone produced a significant elevation of the synthesis in 10 out of 30 brain regions. In both the FSL and FRL rats, buspirone produced rather different effects than those reported previously for SPD (normal) rats. The acute effect in the FSL rats was somewhat similar to the effect reported previously for the SPD rats, while in the FRL rats, the acute buspirone treatment produced an effect observed previously in treatments with 5-HT(1A) antagonists suggesting an action of buspirone as partial agonist in FRL rats. The data suggest that with respect to 5-HT synthesis, FRL rats differ from SPD rats (a natural control; normal rats) and, as such, indicate that when the effects related to the serotonergic system (e.g., influence of serotonergic drugs) are studied in the FSL rats and compared to those in the FRL rats, any conclusions drawn may not reflect differences relative to a normal rat.
本研究的主要目的是评估丁螺环酮(一种具有部分激动剂特性的5-HT(1A)激动剂,也是一种抗抑郁药)对弗林德斯敏感系(FSL)大鼠(“抑郁”型)脑区5-HT合成的影响,并将其与弗林德斯抗性系(FRL)对照大鼠(非“抑郁”型)的影响进行比较。此外,还将结果与先前在正常斯普拉格-道利(SPD)大鼠(正常对照)中报道的结果进行了比较。在用丁螺环酮进行急性和慢性治疗后,测量了FSL和FRL大鼠的血清素合成。这两个品系均源自SPD大鼠。未对FSL生理盐水组和FRL生理盐水组或FSL丁螺环酮组和FRL丁螺环酮组进行直接比较,因为研究目的是评估丁螺环酮在这两个品系中的作用。结果表明,丁螺环酮急性治疗可提高FRL大鼠全脑的5-HT合成。在FSL大鼠中,一些脑区(如背侧和中缝核、杏仁核、前嗅核、黑质网状部)的5-HT合成减少,而在其他脑区(如额叶、顶叶、视觉和躯体感觉皮层、腹侧海马体)则观察到合成增加。在FSL大鼠研究的30个脑区中的20个脑区,丁螺环酮急性治疗后合成无显著变化。在慢性治疗期间,丁螺环酮使FRL大鼠30个脑区中的15个脑区的5-HT合成显著降低。在FSL大鼠中,丁螺环酮使30个脑区中的10个脑区的合成显著升高。在FSL和FRL大鼠中,丁螺环酮产生的效应与先前报道的SPD(正常)大鼠的效应有很大不同。FSL大鼠的急性效应与先前报道的SPD大鼠的效应有些相似,而在FRL大鼠中,丁螺环酮急性治疗产生的效应与先前用5-HT(1A)拮抗剂治疗时观察到的效应相似,这表明丁螺环酮在FRL大鼠中作为部分激动剂起作用。数据表明,就5-HT合成而言,FRL大鼠与SPD大鼠(自然对照;正常大鼠)不同,因此表明,当在FSL大鼠中研究与血清素能系统相关的效应(如血清素能药物的影响)并与FRL大鼠中的效应进行比较时,得出的任何结论可能无法反映相对于正常大鼠的差异。